InvestorsHub Logo
Followers 16
Posts 1545
Boards Moderated 0
Alias Born 12/13/2009

Re: growingpain post# 369003

Wednesday, 08/03/2022 1:51:22 PM

Wednesday, August 03, 2022 1:51:22 PM

Post# of 462570

TGD does not take a bit more risk with launching new trials or recruiting more patients in the existing ones.



The pace of the overall program has been agonizingly slow. I can't imagine why he hasn't moved faster on PD given how large that indication is. Another PD trial could have been well underway, and we would have better cushion in the event the AD trial doesn't work out. And then there is Rett's, which, irrespective of the Avatar sucess, is held back by the timeline of the Excellence trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News